![](/img/cover-not-exists.png)
A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis
Michels, Gina M., Walsh, Kelly F., Kryda, Kristina A., Mahabir, Sean P., Walters, Rodney R., Hoevers, Jacquelien D., Martinon, Olivier M.Language:
english
Journal:
Veterinary Dermatology
DOI:
10.1111/vde.12364
Date:
August, 2016
File:
PDF, 294 KB
english, 2016